(Q61866091)

English

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sebastiano Sciarretta

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Andrea Ferrucci

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Francesco Paneni

2

object named as

Francesco Paneni

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Francesca Palano

3

object named as

Francesca Palano

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Theodore Kurtz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Giuseppe Mancia

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

17 February 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

582-590

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

European comparison of costs and quality in the prevention of secondary complications in Type 2 diabetes mellitus (2000-2001).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

New-onset diabetes and antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

New-onset diabetes, antihypertensive treatment, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials)

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ramipril on the incidence of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Telmisartan to prevent recurrent stroke and cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of valsartan on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramipril and the development of diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Next generation multifunctional angiotensin receptor blockers

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diuretics.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

New onset diabetes during antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive therapy and new onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2011.8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/AJH.2011.8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21331058%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61866091&oldid=1742932597"